Smith-Kingsmore syndrome Last updated June 21, 2025 Medical condition
Smith-Kingsmore syndrome Other names SKS, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, MINDS syndrome [ 1] Smith-Kingsmore Syndrome is inherited in Autosomal Dominant fashion. Causes Gain-of-function mutation in MTOR
Smith-Kingsmore syndrome is a rare genetic disorder that is caused by gain-of-function mutation in an mTOR gene . The facial features of this syndrome are triangular face with a pointed chin, frontal bossing , hypertelorism , eyes with downslanting palpebral fissures , a flat nasal bridge , a long philtrum . [ 2]
Presentation The signs of this disease are: [ 3]
Very frequent:
Intellectual Disability Macrocephaly Frequent:
Abnormal facial shape Abnormality of speech Curly Hair Seizure Frontal bossing Ventriculomegaly Occasional:
Autistic Behaviour Cafe-au-lait spot Gait Disturbance Hypertelorism Hypotonia Open mouth Long philtrum Polymicrogyria Prominient forehead Very rare:
Downslanted palpebral fissures Depressed nasal bridge Decreased circulating IgA level A photo showing 4 patients showing characteristic facial signs of Smith-Kingsmore syndrome. Diagnosis SKS is a rare condition so many physicians aren’t familiar with. A diagnosis of SKS is suspected based upon the identification of symptoms, a patient and family history and a thorough clinical evaluation. [ 7]
SKS can be confirmed with the detection of a germline or mosaic mutation in the MTOR gene. [ 7]
Frequency Frequency of this disease is unknown, but all ethnic groups are equally affected [ 8]
Treatment There is no cure for SKS, but management of some symptoms can be achieved [ 9]
History SKS was first described by Dr Smith, L.D et al. in 2013. [ 10]
References ↑ https://www.orpha.net/en/disease/detail/457485?name=MINDS&mode=name ↑ "Smith-Kingsmore syndrome: MedlinePlus Genetics" . medlineplus.gov . Retrieved 2025-01-06 . ↑ "Orphanet: Clinical signs and symptoms" . www.orpha.net . Retrieved 2025-01-06 . ↑ Liu, Andrew C.; Shen, Yang; Serbinski, Carolyn R.; He, Hongzhi; Roman, Destino; Endale, Mehari; Aschbacher-Smith, Lindsey; King, Katherine A.; Granadillo, Jorge L.; López, Isabel; Krueger, Darcy A.; Dye, Thomas J.; Smith, David F.; Hogenesch, John B.; Prada, Carlos E. (October 2024). "Clinical and functional studies of MTOR variants in Smith-Kingsmore syndrome reveal deficits of circadian rhythm and sleep-wake behavior" . Human Genetics and Genomics Advances . 5 (4): 100333. doi :10.1016/j.xhgg.2024.100333 . PMC 11342114 . ↑ Allen, Andrew S.; Berkovic, Samuel F.; Cossette, Patrick; Delanty, Norman; Dlugos, Dennis; Eichler, Evan E.; Epstein, Michael P.; Glauser, Tracy; Goldstein, David B.; Han, Yujun; Heinzen, Erin L.; Hitomi, Yuki; Howell, Katherine B.; Johnson, Michael R.; Kuzniecky, Ruben (September 2013). "De novo mutations in epileptic encephalopathies" . Nature . 501 (7466): 217– 221. doi :10.1038/nature12439 . ISSN 1476-4687 . PMC 3773011 . PMID 23934111 . ↑ Mroske, Cameron; Rasmussen, Kristen; Shinde, Deepali N.; Huether, Robert; Powis, Zoe; Lu, Hsiao-Mei; Baxter, Ruth M.; McPherson, Elizabeth; Tang, Sha (2015-11-05). "Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities" . BMC Medical Genetics . 16 (1): 102. doi : 10.1186/s12881-015-0240-8 . ISSN 1471-2350 . PMC 4635597 . PMID 26542245 . 1 2 "Smith-Kingsmore Syndrome - Symptoms, Causes, Treatment | NORD" . rarediseases.org . Retrieved 2025-01-06 . ↑ "Smith-Kingsmore Syndrome - Symptoms, Causes, Treatment | NORD" . rarediseases.org . Retrieved 2025-01-06 . ↑ "Managing/Treating SKS – SKS" . Retrieved 2025-01-06 . ↑ Smith, Laurie D.; Saunders, Carol J.; Dinwiddie, Darrell L.; Atherton, Andrea M.; Miller, Neil A.; Soden, Sarah E.; Farrow, Emily G.; Abdelmoity, Ahmed T. G.; Kingsmore, Stephen F. (2013-09-04). "Exome Sequencing Reveals De Novo Germline Mutation of the Mammalian Target of Rapamycin (MTOR) in a Patient with Megalencephaly and Intractable Seizures" . Journal of Genomes and Exomes . 2013 (2): 63– 72. doi :10.4137/JGE.S12583 . ISSN 2253-5004 . This page is based on this
Wikipedia article Text is available under the
CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.